Loading…

Metabolite analysis of [18F]Florbetaben (BAY 94-9172) in human subjects: a substudy within a proof of mechanism clinical trial

[ 18 F]Florbetaben ([ 18 F]BAY 94-9172) is a promising β-amyloid (Aβ) targeted PET-tracer currently in late stage clinical development. [ 18 F]Florbetaben can assist in the more accurate diagnosis of Alzheimer’s Disease (AD) by non-invasive, in vivo detection of Aβ in the brain. To determine the art...

Full description

Saved in:
Bibliographic Details
Published in:Journal of radioanalytical and nuclear chemistry 2010-06, Vol.284 (3), p.557-562
Main Authors: Patt, M., Schildan, A., Barthel, H., Becker, G., Schultze-Mosgau, M. H., Rohde, B., Reininger, C., Sabri, O.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-p160t-7f1bf2878b6d8df9b94e912edcd1519bb0933d64c5311c5ed7b4673a70c39d1f3
container_end_page 562
container_issue 3
container_start_page 557
container_title Journal of radioanalytical and nuclear chemistry
container_volume 284
creator Patt, M.
Schildan, A.
Barthel, H.
Becker, G.
Schultze-Mosgau, M. H.
Rohde, B.
Reininger, C.
Sabri, O.
description [ 18 F]Florbetaben ([ 18 F]BAY 94-9172) is a promising β-amyloid (Aβ) targeted PET-tracer currently in late stage clinical development. [ 18 F]Florbetaben can assist in the more accurate diagnosis of Alzheimer’s Disease (AD) by non-invasive, in vivo detection of Aβ in the brain. To determine the arterial input function of the PET tracer—as part of a proof of mechanism (PoM) study—arterial samples were drawn from all subjects at predefined time points post injection (p.i.), and the proportion of unchanged tracer [ 18 F]Florbetaben was determined by HPLC analysis. Plasma metabolite profiles were investigated following intravenous administration of 300 MBq (±60 MBq) of [ 18 F]Florbetaben to both, patients with AD and healthy controls (HCs), and various methods for processing the blood samples were evaluated. Addition of acetonitrile to plasma samples (obtained from whole blood by centrifugation) and precipitation of proteins resulted in a recovery of more than 90% of the initial radioactivity in the supernatants. High Performance Liquid Chromatography using a polymer-based column (PRP-1) in conjunction with gradient elution was found to be a suitable method of metabolite analysis of [ 18 F]Florbetaben. HPLC analyses indicated that [ 18 F]Florbetaben is rapidly metabolized in vivo with an estimated initial half-life of about 6 min. A polar metabolite fraction, consisting presumably of more than one component, and (to a smaller extent) of the demethylated derivative of [ 18 F]Florbetaben were time-dependently detected in plasma.
doi_str_mv 10.1007/s10967-010-0514-8
format article
fullrecord <record><control><sourceid>proquest_sprin</sourceid><recordid>TN_cdi_proquest_miscellaneous_902376517</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>902376517</sourcerecordid><originalsourceid>FETCH-LOGICAL-p160t-7f1bf2878b6d8df9b94e912edcd1519bb0933d64c5311c5ed7b4673a70c39d1f3</originalsourceid><addsrcrecordid>eNotkEFLwzAUx4MoOKcfwFtu6iGa17RN4m0Op8LEix5EJCRp6jKydjYpsouf3ZYJD96D_48_jx9C50CvgVJ-E4HKkhMKlNACciIO0AQKIUjGBT1EE5qxkhScwTE6iXFNKZVCsAn6fXZJmzb45LBudNhFH3Fb4w8Qi89FaDsz5q7Bl3ezdyxzIoFnV9g3eNVvdINjb9bOpniL9XjH1Fc7_OPTaiA03nbt0DXMxtmVbnzcYBt8460OOHVeh1N0VOsQ3dn_nqK3xf3r_JEsXx6e5rMl2UJJE-E1mDoTXJiyElUtjcydhMxVtoICpDFUMlaVuS0YgC1cxU1ecqY5tUxWULMputj3Dh999y4mtfHRuhB049o-Kjn44WUBfCCzPRm3nW--XKfWbd8NZqICqkbXau9aDa7V6FoJ9gf3eHGf</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>902376517</pqid></control><display><type>article</type><title>Metabolite analysis of [18F]Florbetaben (BAY 94-9172) in human subjects: a substudy within a proof of mechanism clinical trial</title><source>Springer Nature</source><creator>Patt, M. ; Schildan, A. ; Barthel, H. ; Becker, G. ; Schultze-Mosgau, M. H. ; Rohde, B. ; Reininger, C. ; Sabri, O.</creator><creatorcontrib>Patt, M. ; Schildan, A. ; Barthel, H. ; Becker, G. ; Schultze-Mosgau, M. H. ; Rohde, B. ; Reininger, C. ; Sabri, O.</creatorcontrib><description>[ 18 F]Florbetaben ([ 18 F]BAY 94-9172) is a promising β-amyloid (Aβ) targeted PET-tracer currently in late stage clinical development. [ 18 F]Florbetaben can assist in the more accurate diagnosis of Alzheimer’s Disease (AD) by non-invasive, in vivo detection of Aβ in the brain. To determine the arterial input function of the PET tracer—as part of a proof of mechanism (PoM) study—arterial samples were drawn from all subjects at predefined time points post injection (p.i.), and the proportion of unchanged tracer [ 18 F]Florbetaben was determined by HPLC analysis. Plasma metabolite profiles were investigated following intravenous administration of 300 MBq (±60 MBq) of [ 18 F]Florbetaben to both, patients with AD and healthy controls (HCs), and various methods for processing the blood samples were evaluated. Addition of acetonitrile to plasma samples (obtained from whole blood by centrifugation) and precipitation of proteins resulted in a recovery of more than 90% of the initial radioactivity in the supernatants. High Performance Liquid Chromatography using a polymer-based column (PRP-1) in conjunction with gradient elution was found to be a suitable method of metabolite analysis of [ 18 F]Florbetaben. HPLC analyses indicated that [ 18 F]Florbetaben is rapidly metabolized in vivo with an estimated initial half-life of about 6 min. A polar metabolite fraction, consisting presumably of more than one component, and (to a smaller extent) of the demethylated derivative of [ 18 F]Florbetaben were time-dependently detected in plasma.</description><identifier>ISSN: 0236-5731</identifier><identifier>EISSN: 1588-2780</identifier><identifier>DOI: 10.1007/s10967-010-0514-8</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>Chemistry ; Chemistry and Materials Science ; Diagnostic Radiology ; Hadrons ; Heavy Ions ; Inorganic Chemistry ; Nuclear Chemistry ; Nuclear Physics ; Physical Chemistry</subject><ispartof>Journal of radioanalytical and nuclear chemistry, 2010-06, Vol.284 (3), p.557-562</ispartof><rights>Akadémiai Kiadó, Budapest, Hungary 2010</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-p160t-7f1bf2878b6d8df9b94e912edcd1519bb0933d64c5311c5ed7b4673a70c39d1f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids></links><search><creatorcontrib>Patt, M.</creatorcontrib><creatorcontrib>Schildan, A.</creatorcontrib><creatorcontrib>Barthel, H.</creatorcontrib><creatorcontrib>Becker, G.</creatorcontrib><creatorcontrib>Schultze-Mosgau, M. H.</creatorcontrib><creatorcontrib>Rohde, B.</creatorcontrib><creatorcontrib>Reininger, C.</creatorcontrib><creatorcontrib>Sabri, O.</creatorcontrib><title>Metabolite analysis of [18F]Florbetaben (BAY 94-9172) in human subjects: a substudy within a proof of mechanism clinical trial</title><title>Journal of radioanalytical and nuclear chemistry</title><addtitle>J Radioanal Nucl Chem</addtitle><description>[ 18 F]Florbetaben ([ 18 F]BAY 94-9172) is a promising β-amyloid (Aβ) targeted PET-tracer currently in late stage clinical development. [ 18 F]Florbetaben can assist in the more accurate diagnosis of Alzheimer’s Disease (AD) by non-invasive, in vivo detection of Aβ in the brain. To determine the arterial input function of the PET tracer—as part of a proof of mechanism (PoM) study—arterial samples were drawn from all subjects at predefined time points post injection (p.i.), and the proportion of unchanged tracer [ 18 F]Florbetaben was determined by HPLC analysis. Plasma metabolite profiles were investigated following intravenous administration of 300 MBq (±60 MBq) of [ 18 F]Florbetaben to both, patients with AD and healthy controls (HCs), and various methods for processing the blood samples were evaluated. Addition of acetonitrile to plasma samples (obtained from whole blood by centrifugation) and precipitation of proteins resulted in a recovery of more than 90% of the initial radioactivity in the supernatants. High Performance Liquid Chromatography using a polymer-based column (PRP-1) in conjunction with gradient elution was found to be a suitable method of metabolite analysis of [ 18 F]Florbetaben. HPLC analyses indicated that [ 18 F]Florbetaben is rapidly metabolized in vivo with an estimated initial half-life of about 6 min. A polar metabolite fraction, consisting presumably of more than one component, and (to a smaller extent) of the demethylated derivative of [ 18 F]Florbetaben were time-dependently detected in plasma.</description><subject>Chemistry</subject><subject>Chemistry and Materials Science</subject><subject>Diagnostic Radiology</subject><subject>Hadrons</subject><subject>Heavy Ions</subject><subject>Inorganic Chemistry</subject><subject>Nuclear Chemistry</subject><subject>Nuclear Physics</subject><subject>Physical Chemistry</subject><issn>0236-5731</issn><issn>1588-2780</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNotkEFLwzAUx4MoOKcfwFtu6iGa17RN4m0Op8LEix5EJCRp6jKydjYpsouf3ZYJD96D_48_jx9C50CvgVJ-E4HKkhMKlNACciIO0AQKIUjGBT1EE5qxkhScwTE6iXFNKZVCsAn6fXZJmzb45LBudNhFH3Fb4w8Qi89FaDsz5q7Bl3ezdyxzIoFnV9g3eNVvdINjb9bOpniL9XjH1Fc7_OPTaiA03nbt0DXMxtmVbnzcYBt8460OOHVeh1N0VOsQ3dn_nqK3xf3r_JEsXx6e5rMl2UJJE-E1mDoTXJiyElUtjcydhMxVtoICpDFUMlaVuS0YgC1cxU1ecqY5tUxWULMputj3Dh999y4mtfHRuhB049o-Kjn44WUBfCCzPRm3nW--XKfWbd8NZqICqkbXau9aDa7V6FoJ9gf3eHGf</recordid><startdate>20100601</startdate><enddate>20100601</enddate><creator>Patt, M.</creator><creator>Schildan, A.</creator><creator>Barthel, H.</creator><creator>Becker, G.</creator><creator>Schultze-Mosgau, M. H.</creator><creator>Rohde, B.</creator><creator>Reininger, C.</creator><creator>Sabri, O.</creator><general>Springer Netherlands</general><scope>7TV</scope><scope>C1K</scope></search><sort><creationdate>20100601</creationdate><title>Metabolite analysis of [18F]Florbetaben (BAY 94-9172) in human subjects: a substudy within a proof of mechanism clinical trial</title><author>Patt, M. ; Schildan, A. ; Barthel, H. ; Becker, G. ; Schultze-Mosgau, M. H. ; Rohde, B. ; Reininger, C. ; Sabri, O.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p160t-7f1bf2878b6d8df9b94e912edcd1519bb0933d64c5311c5ed7b4673a70c39d1f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Chemistry</topic><topic>Chemistry and Materials Science</topic><topic>Diagnostic Radiology</topic><topic>Hadrons</topic><topic>Heavy Ions</topic><topic>Inorganic Chemistry</topic><topic>Nuclear Chemistry</topic><topic>Nuclear Physics</topic><topic>Physical Chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Patt, M.</creatorcontrib><creatorcontrib>Schildan, A.</creatorcontrib><creatorcontrib>Barthel, H.</creatorcontrib><creatorcontrib>Becker, G.</creatorcontrib><creatorcontrib>Schultze-Mosgau, M. H.</creatorcontrib><creatorcontrib>Rohde, B.</creatorcontrib><creatorcontrib>Reininger, C.</creatorcontrib><creatorcontrib>Sabri, O.</creatorcontrib><collection>Pollution Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Journal of radioanalytical and nuclear chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Patt, M.</au><au>Schildan, A.</au><au>Barthel, H.</au><au>Becker, G.</au><au>Schultze-Mosgau, M. H.</au><au>Rohde, B.</au><au>Reininger, C.</au><au>Sabri, O.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metabolite analysis of [18F]Florbetaben (BAY 94-9172) in human subjects: a substudy within a proof of mechanism clinical trial</atitle><jtitle>Journal of radioanalytical and nuclear chemistry</jtitle><stitle>J Radioanal Nucl Chem</stitle><date>2010-06-01</date><risdate>2010</risdate><volume>284</volume><issue>3</issue><spage>557</spage><epage>562</epage><pages>557-562</pages><issn>0236-5731</issn><eissn>1588-2780</eissn><abstract>[ 18 F]Florbetaben ([ 18 F]BAY 94-9172) is a promising β-amyloid (Aβ) targeted PET-tracer currently in late stage clinical development. [ 18 F]Florbetaben can assist in the more accurate diagnosis of Alzheimer’s Disease (AD) by non-invasive, in vivo detection of Aβ in the brain. To determine the arterial input function of the PET tracer—as part of a proof of mechanism (PoM) study—arterial samples were drawn from all subjects at predefined time points post injection (p.i.), and the proportion of unchanged tracer [ 18 F]Florbetaben was determined by HPLC analysis. Plasma metabolite profiles were investigated following intravenous administration of 300 MBq (±60 MBq) of [ 18 F]Florbetaben to both, patients with AD and healthy controls (HCs), and various methods for processing the blood samples were evaluated. Addition of acetonitrile to plasma samples (obtained from whole blood by centrifugation) and precipitation of proteins resulted in a recovery of more than 90% of the initial radioactivity in the supernatants. High Performance Liquid Chromatography using a polymer-based column (PRP-1) in conjunction with gradient elution was found to be a suitable method of metabolite analysis of [ 18 F]Florbetaben. HPLC analyses indicated that [ 18 F]Florbetaben is rapidly metabolized in vivo with an estimated initial half-life of about 6 min. A polar metabolite fraction, consisting presumably of more than one component, and (to a smaller extent) of the demethylated derivative of [ 18 F]Florbetaben were time-dependently detected in plasma.</abstract><cop>Dordrecht</cop><pub>Springer Netherlands</pub><doi>10.1007/s10967-010-0514-8</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0236-5731
ispartof Journal of radioanalytical and nuclear chemistry, 2010-06, Vol.284 (3), p.557-562
issn 0236-5731
1588-2780
language eng
recordid cdi_proquest_miscellaneous_902376517
source Springer Nature
subjects Chemistry
Chemistry and Materials Science
Diagnostic Radiology
Hadrons
Heavy Ions
Inorganic Chemistry
Nuclear Chemistry
Nuclear Physics
Physical Chemistry
title Metabolite analysis of [18F]Florbetaben (BAY 94-9172) in human subjects: a substudy within a proof of mechanism clinical trial
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T23%3A36%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_sprin&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metabolite%20analysis%20of%20%5B18F%5DFlorbetaben%20(BAY%2094-9172)%20in%20human%20subjects:%20a%20substudy%20within%20a%20proof%20of%20mechanism%20clinical%20trial&rft.jtitle=Journal%20of%20radioanalytical%20and%20nuclear%20chemistry&rft.au=Patt,%20M.&rft.date=2010-06-01&rft.volume=284&rft.issue=3&rft.spage=557&rft.epage=562&rft.pages=557-562&rft.issn=0236-5731&rft.eissn=1588-2780&rft_id=info:doi/10.1007/s10967-010-0514-8&rft_dat=%3Cproquest_sprin%3E902376517%3C/proquest_sprin%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p160t-7f1bf2878b6d8df9b94e912edcd1519bb0933d64c5311c5ed7b4673a70c39d1f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=902376517&rft_id=info:pmid/&rfr_iscdi=true